A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers.
about
Epidemiology and Prevention of Hepatitis B Virus InfectionHepatitis B virus and its sexually transmitted infection - an update.Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.T-cell tolerance: exposure to virus in utero does not cause a permanent deletion of specific T cellsCost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatmentChanges in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated AreaResponse to booster doses of hepatitis B vaccine among young adults who had received neonatal vaccination.Strategies for hepatitis B immunisation.Immunisation against hepatitis B in Taiwan.Infantile hepatitis B in immunized children: risk for fulminant hepatitis and long-term outcomes.Profile of Ding-Shinn Chen.Seroprevalence of hepatitis B virus among adults at high risk for HIV transmission two decades after implementation of nationwide hepatitis B virus vaccination program in Taiwan.Preventing Hepatitis B-induced Liver Cancer: Implications for Eliminating Health Disparities.Prevention of hepatitis B.Integration of hepatitis B vaccination into rural African primary health care programmes.Hepatitis B vaccination in preterm infants.T cell-based therapies for EBV-associated malignancies.Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers.Viral hepatitis: retrospective review in a canadian pediatric hospital.Age-dependent decrease of anti-HBs titers and effect of booster doses using 2 different vaccines in Palestinian children vaccinated in early childhood.Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients: A Large Cohort Retrospective Study.Increased risk of sudden sensorineural hearing loss in patients with hepatitis virus infection.Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients.Programme for preventing perinatal hepatitis B infection through screening of pregnant women and immunisation of infants of infected mothers in The Netherlands, 1989-92. National Hepatitis B Steering Committee.Paths toward hepatitis B immunization in South Korea and TaiwanThe burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004.Prevalence and determinants of hepatitis B antigenemia in 15,007 inmates in TaiwanNatural history of chronic hepatitis B: what exactly has REVEAL revealed?Hepatitis B virus infection and metabolic syndrome: fact or fiction?Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific.A review of strategies to prevent mother-to-infant transmission of hepatitis B virus infection.Chronic hepatitis B, nonalcoholic steatohepatitis and physical fitness of military males: CHIEF study.Prospects and progress of DNA vaccines for treating hepatitis B.Chronologic changes in serum hepatitis B virus DNA, genotypes, surface antigen mutants and reverse transcriptase mutants during 25-year nationwide immunization in Taiwan.Effect of ultrasonography surveillance in patients with liver cancer: a population-based longitudinal study.Universal infant immunization and occult hepatitis B virus infection in children and adolescents: a population-based study.Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan.Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees.Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan.Early acquisition of TT virus in infants: possible minor role of maternal transmission.
P2860
Q24810152-64C1B703-7D9F-4BEF-9CAB-E18F775E03B5Q30235028-F0C63C08-08DA-4576-BC0C-D544A1B626E6Q30479629-B6BFDE55-338B-41F3-B733-236546C5A281Q33564026-D01EA14B-7B6A-45E7-91A1-4CF6FDF5EA8CQ33587889-2DE06D79-3CD4-49D3-B772-12E76C4CD101Q33682797-EC2DEBA4-00F6-419F-876A-20703B23714DQ34150102-8D520B8D-E4DF-48DA-872A-5415C25AD5E8Q34395230-737B7311-7007-4176-BDAA-CCDF85123854Q34442054-D68899F7-D720-489D-8527-833F07D751D7Q34472882-DA44F2BE-5842-4643-A788-9C39F1CBADA2Q34689074-E53A1B2B-0275-4862-9B15-AC81AB0B2119Q35108823-B5D89857-CDF7-4560-9FB1-0080A503C799Q35116448-5E348A65-3DAB-4E07-AF21-1886189CFFA5Q35164249-BCD54E89-B5FA-4888-A18B-6F7859907FEFQ35178426-75221A1E-740E-434D-9A5E-CA5C89581371Q35285908-B45EC140-F795-425D-B36E-EB0548F9F420Q35609768-78CF7D09-1067-4469-BBA1-0BAA93E73501Q35615341-45C21AA9-CB55-410F-BB01-622F022BF68EQ35864514-8FBE3783-1EDD-4327-9D19-F02D8D35A350Q35887238-DBAB85C4-9EF2-4B3C-A36B-37B88DBF06BDQ36195013-9EE782BB-6CA3-470C-8293-0A71B508EE3BQ36338548-6B506A77-015F-4B0F-8311-703BB9C50C12Q36822761-28A53FA7-12F3-4571-8A31-56A238195316Q36905396-69249EF3-CC4A-490F-9A95-5196CDC90656Q37011014-FCDC91AD-0DDD-4AEB-8EEB-8F01DABFA350Q37421369-FBF87D32-95D2-4091-8AEC-04EF458AA97EQ37511339-2F91652F-2147-4031-8D3F-F3E9F6F23B42Q38003214-C3AE4CD3-78D7-4EB1-910C-F55BD211AE63Q38236996-19F8A20D-5955-4050-937B-92C7BC3F48AEQ38552383-64C084E4-C5C2-40AF-BD18-50BA5C41CD4BQ38632945-EE5FDA92-DB5E-4E0B-9CD5-1740DF7CB985Q38652393-9DC5857D-4CA7-41FC-AEF4-C1C16583ABD0Q38664504-B34406BD-AA0F-4E1B-B4AC-BB747BF4F0CBQ38969885-2564F8C7-6704-4015-BD75-2F2867B2F520Q40147468-4257EEC5-B33F-489D-A881-BDD6E756420EQ41602121-AA28F2AB-AF8D-46BD-A8DD-0EA787B7A613Q42177592-5C5D1A8D-ECEA-45F2-9F4C-8BCA5EA1AFB7Q42229775-FCAEABFA-C4D0-41D4-AB71-AEA55A5A9A73Q42993083-4522F594-3B27-471B-A0D9-805F6B4F0A58Q43035995-BD439DD3-C100-4B1A-B748-7DC9458EE9FD
P2860
A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
A mass vaccination program in ...... rface antigen-carrier mothers.
@en
A mass vaccination program in ...... rface antigen-carrier mothers.
@nl
type
label
A mass vaccination program in ...... rface antigen-carrier mothers.
@en
A mass vaccination program in ...... rface antigen-carrier mothers.
@nl
prefLabel
A mass vaccination program in ...... rface antigen-carrier mothers.
@en
A mass vaccination program in ...... rface antigen-carrier mothers.
@nl
P2093
P1476
A mass vaccination program in ...... rface antigen-carrier mothers.
@en
P2093
P304
P356
10.1001/JAMA.1987.03390190075023
P407
P577
1987-05-01T00:00:00Z